To confirm the microarray results, five differentially expressed lncRNAs (AK012226, B430212C06Rik, Fabp3-ps1, NR-040532, and AK052193) were selected for qPCR validation in the liver samples of the NAFLD and control groups. The gene discussed is FABP3; the disease is metabolic dysfunction-associated steatotic liver disease.